Prakash Raman

Prakash Raman

Director/Board Member at BLACK DIAMOND THERAPEUTICS, INC.

Net worth: 94 582 $ as of 2026-08-30

56 year
Health Technology
Commercial Services
Consumer Services

Profile

Dr. Prakash Raman is an Independent Director at Olema Pharmaceuticals, Inc., a Chief Executive Officer at Indupro, an Independent Director at Black Diamond Therapeutics, Inc., a Chief Executive Officer & Director at InduPro, Inc. and a President, Chief Executive Officer & Director at Ribon Therapeutics, Inc. He is on the Board of Directors at Olema Pharmaceuticals, Inc., Black Diamond Therapeutics, Inc., InduPro, Inc. and Ribon Therapeutics, Inc. Dr. Raman was previously employed as a VP & Global Head-NIBR Business Development by Novartis Institutes for Biomedical Research, Inc. and a Head-Project Management by AstraZeneca PLC.
He also served on the board at KSQ Therapeutics, Inc. and NAYA Therapeutics, Inc. He received his undergraduate degree from Indian Institute of Technology Bombay, a graduate degree from Indian Institute of Technology Bombay and a doctorate degree from the University of Wisconsin-Madison.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-25 45,039 ( 0.08% ) 94 582 $ 2026-08-30
2026-06-17 0 ( -.--% ) - $ 2026-08-30

Prakash Raman active positions

CompaniesPositionStart
BLACK DIAMOND THERAPEUTICS, INC. Director/Board Member 2024-04-09
OLEMA PHARMACEUTICALS, INC. Director/Board Member 2026-04-27
Chief Executive Officer 2022-02-16
Indupro
Chief Executive Officer 2024-06-12
Chief Executive Officer 2024-03-31

Former positions of Prakash Raman

CompaniesPositionEnd
Corporate Officer/Principal 2019-09-30
ASTRAZENECA PLC Corporate Officer/Principal 2012-10-31
Chief Executive Officer -
See the detail of Prakash Raman's experience

Training of Prakash Raman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Indupro

Commercial Services

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!